Reference
Ma C, et al. Corrigendum: Afatinib for advanced non-small cell lung cancer in a case with an uncommon epidermal growth factor receptor mutation (g719a) identified in the cerebrospinal fluid (Front. Oncol., (2019), 9, 10.3389/fonc.2019.00628). Frontiers in Oncology 9: Sep 2019. Available from: URL: http://doi.org/10.3389/fonc.2019.00938 - China
Rights and permissions
About this article
Cite this article
Afatinib. Reactions Weekly 1779, 18 (2019). https://doi.org/10.1007/s40278-019-71282-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-71282-x